Development of a UV-Vis Spectroscopic Method for Etodolac Determination and Evaluation of Pharmaceutical Additive Effects

Yıl 2025, Cilt: 8 Sayı: 3, 178 - 186, 23.12.2025

Hosna Adib , Iraj Karimpour , Sevda Akay Sazaklioglu

https://doi.org/10.38001/ijlsb.1717622

Öz

Etodolac is an active substance from the nonsteroidal anti-inflammatory drug (NSAID) class and is widely used in the treatment of pain and inflammation. In this study, a simple, rapid, and sensitive UV-Vis spectrophotometric method was developed and validated for the quantitative determination of etodolac from commercial tablet formulations. Etodolac showed maximum absorbance at 278 nm. Methanol was optimized as the most suitable solvent in the study, and the method was validated according to these conditions. The method demonstrated a linear working range of 0.88- 40 µg mL-1. The limit of detection (LOD) was found to be 0.29 µg mL-1. Additionally, the effects of some pharmaceutical excipients on the UV absorbance of etodolac were investigated. Pharmaceutical excipients can cause changes in the UV absorbance of the active ingredient, which can lead to incorrect dosage determinations and analytical errors. In this context, the effect of mannose, lactose monohydrate, and potassium sorbate on the maximum absorbance of etodolac at 278 nm was evaluated, and possible interferences were examined. In addition, stability studies were carried out for four weeks to test the long-term reliability of the analysis method. Moreover, the recovery of etodolac from the Etotio tablet formulation was measured, and the method's accuracy was evaluated. The data showed that the applied analysis method offers high precision, reproducibility, and reliability. This study presents an optimized, sensitive, and selective method for accurately quantifying etodolac in pharmaceutical preparations.

Anahtar Kelimeler

Etodolac , Analytical method , UV-Vis spectroscopy , Pharmaceutical analysis , Drug additives

Etik Beyan

The study is proper with ethical standards.

Teşekkür

The authors thank Dr. İbrahim Murat ÜZER for his valuable support in improving this paper.

Etodolak Tayini ve Farmasötik Katkı Maddesi Etkilerinin Değerlendirilmesi için UV-Vis Spektroskopik Yöntem Geliştirilmesi

Öz

Etodolak, nonsteroidal antiinflamatuar ilaç (NSAID) sınıfından bir aktif maddedir ve ağrı ve inflamasyon tedavisinde yaygın olarak kullanılır. Bu çalışmada, ticari tablet formülasyonlarından etodolakın kantitatif tayini için basit, hızlı ve hassas bir UV-Vis spektrofotometrik yöntem geliştirildi ve doğrulandı. Etodolak 278 nm'de maksimum absorbans gösterdi. Metanol, çalışmada en uygun çözücü olarak optimize edildi ve yöntem bu koşullara göre doğrulandı. Yöntem, 0,88-40 µg mL-1'lik doğrusal bir çalışma aralığı gösterdi. Tespit sınırı (LOD) 0,29 µg mL-1 olarak bulundu. Ayrıca, bazı farmasötik yardımcı maddelerin etodolak'ın UV absorbansı üzerindeki etkileri araştırıldı. Farmasötik yardımcı maddeler, aktif maddenin UV absorbansında değişikliklere neden olabilir, bu da yanlış dozaj belirlemelerine ve analitik hatalara yol açabilir. Bu bağlamda, mannoz, laktoz monohidrat ve potasyum sorbatın etodolakın 278 nm'deki maksimum absorbansı üzerindeki etkisi değerlendirildi ve olası girişimler incelendi. Ayrıca, analiz yönteminin uzun vadeli güvenilirliğini test etmek için dört hafta boyunca stabilite çalışmaları yürütüldü. Dahası, Etotio tablet formülasyonundan etodolak geri kazanımı ölçüldü ve yöntemin doğruluğu değerlendirildi. Veriler, uygulanan analiz yönteminin yüksek hassasiyet, tekrarlanabilirlik ve güvenilirlik sunduğunu gösterdi. Bu çalışma, farmasötik preparatlarda etodolakın doğru bir şekilde ölçülmesi için optimize edilmiş, hassas ve seçici bir yöntem sunmaktadır

Anahtar Kelimeler

Etodolak , Analitik yöntem , UV-Vis spektroskopisi , İlaç analizi , İlaç katkı maddeleri

Kaynakça

• References
• 1. Schmidt, M., Sørensen. H,T., and Pedersen, L., Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials. Drug Safety, 2022. 45.9: p. 983–994. https://doi.org/10.1007/s40264-022-01211-1
• 2. Porat, D., Dukhno, O., Partook-Maccabi, M., Vainer, E., Cvijić, S., and Dahan, A., Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokinetics. International Journal of Pharmaceutics, 2023. 645. p. 123347-123362. https://doi.org/10.1016/j.ijpharm.2023.123347
• 3. Alanazi, A.Z., Alhazzani, K., Mostafa, A.M., Barker. J., El-Wekil. M.M., Ali. A.M.B.H., Selective and reliable fluorometric quantitation of anti-cancer drug in real plasma samples using nitrogen-doped carbon dots after MMIPs solid phase microextraction: Monitoring methotrexate plasma level. Journal of Pharmaceutical and Biomedical Analysis, 2024. 238 115862-115869. https://doi.org/10.1016/j.jpba.2023.115862
• 4. Dogruer-Erkok, S., Gallois, R., Leegwater, L., Gonzalez, P.C, van Asten A, and McCord B., Combining surface-enhanced Raman spectroscopy (SERS) and paper spray mass spectrometry (PS-MS) for illicit drug detection. Talanta, 2024. 278. p.126414-126425. https://doi.org/10.1016/j.talanta.2024.126414
• 5. Picollo, M., Aceto, M., and Vitorino, T., UV-Vis spectroscopy. Physical Sciences Reviews, 2019. 4.4. https://doi.org/10.1515/psr-2018-0008
• 6. Li, F., Wang, X., Yang, M., Zhu, M., Chen, W., Li, Q., Sun, D., Bi, X., Maletskyi, Z., and Ratnaweera, H., Detection Limits of Antibiotics in Wastewater by Real-Time UV–VIS Spectrometry at Different Optical Path Length. Processes, 2022. 10.12: p.2614-2628. https://doi.org/10.3390/pr10122614
• 7. Kumar, A.K.H., Sudha, V., Swaminathan, S., and Ramachandran, G., Comparison of HPLC & spectrophotometric methods for estimation of antiretroviral drug content in pharmaceutical products. The Indian Journal of Medical Research, 2010. 132.10: p.390-394.
• 8. Gouda, A.A., and Hassan, W.S., Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations. Chemistry Central Journal, 2008. 14.2: p.7-14. https://doi.org/10.1186/1752-153X-2-7
• 9. Bhusari, S., Rathod, P., Wakte, P., Development and Validation of Uv-Visible Spectrophotometric Method for Etodolac. International Journal of Pharmaceutical Research and Applications, 2022. 7:1392-1397. https://doi.org/10.35629/7781-070113921397
• 10. Mrotek, E., Dudziak, S., Malinowska, I., Pelczarski, D., Ryżyńska, Z., and Zielińska-Jurek, A., Improved degradation of etodolac in the presence of core-shell ZnFe2O4/SiO2/TiO2 magnetic photocatalyst. Science of the Total Environment, 2020. 724. P. 138167-138178. https://doi.org/10.1016/j.scitotenv.2020.138167
• 11. Tripathi, D., Sahoo, J., Sharma, D.K., and Raman, S.K., Ecologically Validated UV Method for Etodolac Estimation in Pharmaceutical Formulation Using Green Hydrotropic Solution and Forced Degradation Study for Stability Detection. Letters in Applied NanoBioScience, 2024. 13.1: p.14-26. https://doi.org/10.33263/LIANBS131.014
• 12. Shi, Z., Chow, C.W.K., Fabris, R., Liu, J., and Jin, B., Applications of Online UV‐Vis Spectrophotometer for Drinking Water Quality Monitoring and Process Control: A Review. Sensors, 2022. 22.8: p.2987- 3007. https://doi.org/10.3390/s22082987
• 13. Picollo, M., Aceto, M., Vitorino, T., UV-Vis spectroscopy. Physical Sciences Reviews, 2019. 4.4. https://doi.org/10.1515/psr-2018-0008
• 14. Demirci-Insuyu, P., Atila, A., Kadioglu, Y., and Turan, A., Quantitative Determination of Etodolac by UV Spectrophtometric Method in Bulk Drug and Commercial Formulations. International Journal of Pharmaceutical Sciences and Research, 2013. 4.8: p.2927–2932. https://doi.org/10.13040/IJPSR.0975-8232.4(8).2927-32
• 15. Albayrak, M., Demirkaya-Miloglu, F., Senol, O., and Polatdemir, E., Design, optimization, and validation of chemometrics-assisted spectrophotometric methods for simultaneous determination of etodolac and thiocolchicoside in pharmaceuticals. Journal of Analytical Science and Technology, 2019. 10.16: p.1-8. https://doi.org/10.1186/s40543-019-0176-2
• 16. Parimala-Devi, C., Prasanna, L.M., and Sree, L.G., Determination of Evaluation Parameters of Etodolac Compared with Standard By Using Uv-Spectrophotometer. World Journal of Pharmaceutical Research, 2020. 9.4: p.1073-1087. https://doi.org/10.20959/wjpr20204-17081 17. Shaikh, A., Singh, G., Jain, N.K., and Gupta, M.K., Development And Validatıon of New Simple, Sensitive and Validated Uv-Spectrophotometric and Rp-Hplc Method for the Simultaneous Estimation of Paracetamol and Etodolac in Marketed Formulation. Journal of Drug Delivery and Therapeutics, 2017. 7.4: p.120-124. https://doi.org/10.22270/jddt.v7i4.1476
• 18. de Miranda Silva, C., Rocha, A., Tozatto, E., da Silva, L.M., Donadi, E.A., and Lanchote, V.L., Enantioselective analysis of etodolac in human plasma by LC-MS/MS: Application to clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis, 2016. 20.120: p.120–126. https://doi.org/10.1016/j.jpba.2015.12.009
• 19. Yılmaz, S., Uslu, B., and Ozkan, S.A., Anodic oxidation of etodolac and its square wave and differential pulse voltammetric determination in pharmaceuticals and human serum. Talanta, 2001. 54.2: p. 351-360. https://doi.org/10.1016/S0039-9140(00)00653-6
• 20. Ulu, S.T., New and sensitive spectrofluorimetric method for the determination of non-steroidal anti inflammatory drugs, etodolac and diclofenac sodium in pharmaceutical preparations through derivatization with 7-fluoro-4-nitrobenzo-2- oxa-1,3-diazole. Journal of Food and Drug Analysis, 2011. 19.1: p.94–101. https://doi.org/10.38212/2224-6614.2202
• 21. Jain, R., and Shrivastava, S., A Graphene-Polyaniline-Bi2O3 Hybrid Film Sensor for Voltammetric Quantification of Anti-Inflammatory Drug Etodolac. Journal of The Electrochemical Society, 2014. 161.4: p.189–194. https://doi.org/10.1149/2.043404jes
• 22. Taverniers, I., De Loose, M., and Van Bockstaele, E., Trends in quality in the analytical laboratory. II. Analytical method validation and quality assurance. TrAC-Trends in Analytical Chemistry, 2004. 23.8: p.535–552. https://doi.org/10.1016/j.trac.2004.04.001